For years, the U.S. healthcare industry has been evolving across its key sectors—providers, payers, pharmacy services, and healthcare services and technology (HST). This evolution has come with increasing complexity, as organizations face economic pressures, workforce shortages, and growing patient demands. At the same time, technological advancements, including artificial intelligence (AI), are opening new pathways for efficiency and growth.
A recent report from McKinsey & Company highlights the critical challenges and opportunities ahead as the industry moves toward 2025. With inflationary pressures, regulatory scrutiny, and rising utilization rates at play, organizations must adopt innovative strategies to thrive. The report also underscores an essential truth: the healthcare industry’s ability to unlock $1 trillion in value lies in improving care delivery, enhancing productivity, and embracing technology.
Let’s take a closer look at each sector and how these challenges and opportunities are expected to unfold.
Providers: Balancing Stability and Innovation
The provider sector has faced unprecedented challenges in recent years, many of which can be traced back to the COVID-19 pandemic. Workforce shortages, rising supply costs, and inflation have constrained financial growth. Between 2019 and 2024, McKinsey estimates aggregate annual EBITDA (earnings before interest, taxes, depreciation, and amortization) growth at just 2%, lagging far behind the 6% growth seen in national health expenditures (NHEs).
However, recovery is on the horizon. The CARES Act and Medicaid expansion have helped stabilize provider performance, with some regions returning to pre-pandemic levels. To sustain this momentum, providers will need to focus on operational efficiency and technological advancements, including AI-powered tools. Generative AI, for instance, holds enormous potential to streamline clinical operations, revenue cycles, and patient access processes. McKinsey estimates that AI could generate annual savings of $24 to $48 billion for hospitals and $10 to $30 billion for physician groups by reducing administrative costs alone.
Providers must also capitalize on areas of growth that align with patient preferences. Ambulatory surgery centers (ASCs) and home health services, for example, are expected to expand at a 7% annual rate through 2028. These care settings, which offer lower costs and greater convenience, align with broader trends toward value-based care and increased reimbursement options. Shifting services to lower-acuity settings could reduce annual healthcare spending by $114 to $148 billion.
Nevertheless, providers face a competitive landscape. New entrants—from private equity to retail clinics—are posing significant challenges. Maintaining financial stability will require balancing hospital-based operations with investments in outpatient care, technology, and workforce solutions.
Payers: Overcoming Profitability Strains and Driving Innovation
The payer sector has not been immune to mounting pressures. Rising utilization rates, provider cost inflation, and regulatory changes have strained profitability, forcing many payers to operate below breakeven levels in recent years. Looking ahead, margin recovery will require a combination of cost containment, product innovation, and a renewed focus on core growth areas like Medicare Advantage (MA) and Managed Medicaid.
Medicare Advantage remains a key battleground, as payers contend with rising competition, regulatory oversight, and lower Star Ratings. While Managed Medicaid enrollment has declined, opportunities still exist, particularly in transitioning fee-for-service members to managed care and expanding Medicaid coverage in certain states.
In the commercial market, employers—especially small and midsized businesses—are seeking affordable alternatives. Fully insured membership is declining, while self-insured plans are gaining traction. A promising area of innovation lies in individual coverage health reimbursement arrangements (ICHRAs), which allow employers to contribute tax-advantaged funds toward employee coverage. ICHRAs are expected to see a 29% adoption increase between 2023 and 2024, offering payers a viable path for growth.
Technology will play a central role in driving these strategies forward. By leveraging AI and automation, payers can reduce administrative costs by $150 to $300 million and medical costs by $380 to $970 million for every $10 billion in revenue. Innovation in product offerings, such as value-based and hybrid health plans, will be critical for attracting employers and consumers alike.
Pharmacy Services: Managing Margins, Innovations, and Transparency
The pharmacy sector—a critical component of health care—faces a dual narrative of challenges and opportunities. On one hand, retail pharmacies are grappling with margin pressures fueled by inflation, labor shortages, and rising real estate costs. Pharmacy benefit managers (PBMs), meanwhile, are under increasing scrutiny for transparency in pricing and rebates.
On the other hand, the pharmaceutical landscape is evolving rapidly, with specialty drugs, biosimilars, and novel therapies offering significant growth potential. Biosimilars alone have saved the healthcare system $56 billion over the past decade and are expected to continue gaining market share. Specialty drugs, particularly in oncology, neurology, and immunology, are projected to grow at an 8% compound annual growth rate (CAGR) through 2028. Similarly, cell and gene therapies are expanding their reach, with spending forecasted to triple to $28 billion by 2030.
Innovative care models are also reshaping the pharmacy sector. Integrated medical-pharmacy programs are showing promise for cost savings and improved outcomes. For instance, a pharmacy care management program reduced costs for medically complex Medicare Advantage members by $108 per member, per month within a year. Direct-to-consumer pharmacy delivery services are emerging as well, though adoption remains in its early stages.
Addressing transparency and pricing challenges will be paramount. Organizations that invest in integrated care delivery, partnerships, and innovative models will be better positioned to meet growing demands while mitigating regulatory risks.
Health Care Services and Technology: Powering the Future
The healthcare services and technology (HST) sector has been a bright spot in the industry, driven by rising demand for data, analytics, and software solutions. Since 2019, the sector has achieved a 9% annual growth rate, and McKinsey projects similar growth through 2028. Subsegments like generative AI, advanced analytics, and cybersecurity are particularly well-positioned for expansion.
However, the HST sector remains highly fragmented, with the top 10 companies accounting for just 25% of total revenue. This fragmentation—coupled with challenges like limited data interoperability, regulatory hurdles, and a diverse customer base—presents both risks and opportunities.
To unlock further growth, vendors must prioritize deep vertical expertise and seamless technology integration. Leveraging generative AI for customer acquisition, improving data interoperability, and enhancing actionable insights are key priorities. Robust cybersecurity measures will also be essential as healthcare organizations handle increasingly complex and sensitive data.
The HST sector’s growth potential underscores its importance in addressing broader industry challenges. By enabling providers, payers, and pharmacies to operate more efficiently and deliver better outcomes, the HST sector will play a central role in shaping the future of U.S. health care.
Moving Forward: Patient-Centered, Technology-Enabled Care
As the healthcare industry faces significant hurdles, the path forward lies in innovation and collaboration. Providers, payers, pharmacy services, and HST organizations must embrace a patient-centered approach while leveraging cutting-edge technologies to enhance efficiency, reduce costs, and improve outcomes.
McKinsey’s projections offer a clear vision of what’s possible. By pursuing opportunities in care delivery transformation, administrative simplification, and technology enablement, the healthcare industry has the potential to unlock $1 trillion in value. From AI-powered tools to innovative care models, the future holds immense promise for organizations willing to adapt, invest, and lead the way.
In an industry as complex and vital as health care, the challenges of today are the opportunities of tomorrow. By focusing on technology-driven solutions, patient needs, and operational resilience, the healthcare sector is well-positioned to navigate the road ahead and deliver a brighter, more sustainable future for all.
Discover more from Doctor Trusted
Subscribe to get the latest posts sent to your email.
